Therefore, we investigated the impact of SIRPα antagonism on antitumor immunity in mouse tumor models using hAB21 as a monotherapy or in combination with an antitumor antibody or T cell checkpoint inhibitors. The gene discussed is SIRPA; the disease is neoplasm.